Inactive Instrument

News BIO-TECHNE Corp Nasdaq

Equities

US8783771004

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 23	Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	MT
Apr. 18	Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	Apr. 23	MT
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	Apr. 23	PR
Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85	Apr. 18	MT
BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS	Apr. 10	PR
RBC Raises Price Target on Bio-Techne to $79 From $75, Keeps Sector Perform Rating	Apr. 08	MT
BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY	Apr. 08	PR
BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS	Apr. 01	PR
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	Mar. 28	MT
BIO-TECHNE AND NIKON INSTRUMENTS INC. ANNOUNCE PARTNERSHIP TO EXPAND ACCESS TO INNOVATIVE SPATIAL BIOLOGY SERVICES	Mar. 28	PR
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	Mar. 25	AQ
Bio-Techne Says European Union IVDR Certification Received for Diagnostic Test Tracking Chronic Myeloid Leukemia	Mar. 22	MT
BIO-TECHNE RECEIVES EUROPEAN IVDR CERTIFICATION FOR DIAGNOSTIC TEST TO MONITOR CHRONIC MYELOID LEUKEMIA	Mar. 22	PR
Transcript : Bio-Techne Corporation Presents at KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum, Mar-19-2024 09:45 AM	Mar. 19
Transcript : Bio-Techne Corporation Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 08:30 AM	Mar. 13
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES AND MEDTECH INVESTOR FORUM	Mar. 13	AQ
BIO-TECHNE TO PRESENT AT THE KEYBANC LIFE SCIENCES & MEDTECH INVESTOR FORUM	Mar. 12	PR
BIO-TECHNE TO PRESENT AT THE BARCLAYS 26th ANNUAL GLOBAL HEALTHCARE CONFERENCE	Mar. 06	PR
Ex-dividend day	Feb. 08	FA
North American Morning Briefing : Hopes of March -2-	Feb. 05	DJ
Stephens Adjusts Bio-Techne's Price Target to $87 From $70, Keeps Overweight Rating	Feb. 02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News BIO-TECHNE Corp Nasdaq

Equities

US8783771004

Summary

Filters